See the DrugPatentWatch profile for Ranolazine
What is ranolazine, and what class does it belong to?
Ranolazine is a medication used for certain types of angina (chest pain). It is classified as an antianginal drug, and more specifically it is often grouped as a sodium-channel inhibitor (used to help improve heart blood flow and reduce angina symptoms).
What condition is ranolazine used for?
Ranolazine is used to help treat chronic angina (stable angina), especially in people whose angina is not fully controlled by other medicines or who cannot tolerate some standard options.
How does ranolazine work compared with typical angina drugs?
Many common angina treatments work by changing heart rate and blood pressure (for example, beta blockers and nitrates). Ranolazine’s approach is different because it targets ion channels in heart cells, which helps reduce angina symptoms without directly relying on lowering heart rate or blood pressure as the main mechanism.
What are common side effects people ask about?
People taking ranolazine may experience side effects such as dizziness, headache, constipation, nausea, and fatigue. Some patients also report weakness or lightheadedness.
What are key safety concerns and drug interactions?
Ranolazine can interact with other medicines, especially those that affect how it is processed in the body (drug-metabolism pathways). It may also affect heart electrical activity (QT prolongation), so clinicians pay attention to other QT-prolonging drugs and to patient risk factors.
Who should avoid or use extra caution with ranolazine?
Extra caution is typically needed in people with known QT prolongation risk, significant liver impairment, or those taking interacting medications. Dosing and monitoring are important because ranolazine’s safety depends on avoiding harmful drug combinations and keeping levels in a safer range.
Is ranolazine available under brand names?
Ranolazine is marketed under brand names in different countries (commonly recognized in the US as Ranexa).
Where it fits in angina treatment plans
Clinicians generally use ranolazine as an add-on or alternative in chronic angina management when standard therapies do not control symptoms well or cannot be used.
Sources
I don’t have any provided references in your prompt, so I can’t cite specific sources. If you share the materials you want me to use (or allow me to search), I can give a source-backed answer with exact classification language and interaction details.